ABVC BioPharma, Inc. Revenue, Remaining Performance Obligation, Percentage
ABVC BioPharma, Inc. (ABVC) had Revenue, Remaining Performance Obligation, Percentage of 100.00% as of 2024-03-31, per its 10-Q filed 2024-05-17.
Financial Statements › Notes
us-gaap:RevenueRemainingPerformanceObligationPercentage · last filed 2024-11-14
- 2024-03-31: Revenue, Remaining Performance Obligation, Percentage 100.00%.
- 2023-09-30: Revenue, Remaining Performance Obligation, Percentage 81.19%.
- 2023-03-31: Revenue, Remaining Performance Obligation, Percentage 84.78%.
| Period end | Revenue, Remaining Performance Obligation, Percentage |
|---|---|
| 2024-03-31 | 100.00% 10-Q · filed 2024-05-17 |
| 2023-09-30 | 81.19% 10-Q · filed 2024-11-14 |
| 2023-03-31 | 84.78% 10-Q · filed 2024-05-17 |